Cat.#: ACPP-1346
| Despition | GFAP Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1081 | Human NRN1 Protein (AC1081) | 5 µg | inquiry |
| ACPP-1352 | Myocilin Blocking Peptide (AC1352) | 250 µg | inquiry |
| ACPP-1321 | NPY5R Blocking Peptide (AC1321) | 250 µg | inquiry |
| ACPP-1302 | Noelin Blocking Peptide (AC1302) | 250 µg | inquiry |
| ACPP-1673 | Human TIMM8A Protein (AC1673) | 5 µg | inquiry |
| ACPP-1821 | Human NT 4 Protein (AC1821) | 2 µg | inquiry |
| ACPP-1743 | Human SCG5 Protein (AC1743) | 2 µg | inquiry |
| ACPP-1449 | Human IL 6 Protein, CHO (AC1449) | 5 µg | inquiry |
| ACPP-1834 | Human BAALC Protein (AC1834) | 2 µg | inquiry |
| ACPP-1083 | Recombinant Human SIRP alpha Protein (Fc Chimera 6xHis Tag) (AC1083) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.